Dr. Serguei

Yesterday I had the opportunity to attend the 8th Annual Rotary Club of Homestead Stone Crab & Seafood Festival. Events like this reminds us how powerful local initiatives can be. The Rotary Club of Homestead Charitable Foundation raises funds to support college scholarships for local youth, the Homestead Soup Kitchen, and other nonprofit organizations serving families in our community.

Beyond the incredible seafood, the festival created a wonderful atmosphere with live music and arts@to enjoy a day with the family. Get your tickets at www.homesteadseafoodfestival.com

🗓️ March 8 | 11:00 AM - 6:00 PM
📍 Homestead Sports Complex
👶🏻Kids 12 & under Free

Did you know? The Dolphins Cancer Challenge has raised nearly $100 million since 2010, all benefiting groundbreaking cancer research at Sylvester Comprehensive Cancer Center.

These funds support:
🔬 Innovative clinical trials
🧬 Precision medicine research
💊 New drug development
👩‍⚕️ Translational therapies that move discoveries from lab to patient care

Research is how we move from hope to cure.

That’s why I walk.

Join me or support the cause today.

______

¿Sabías que? El “The Dolphins Cancer Challenge” ha recaudado casi 100 millones de dólares desde 2010, en su totalidad para la investigación pionera del cáncer en el Centro Oncológico Integral Sylvester.

Estos fondos apoyan:
🔬 Ensayos clínicos innovadores
🧬 Investigación en medicina de precisión
💊 Desarrollo de nuevos fármacos
👩‍⚕️ Terapias traslacionales que trasladan los descubrimientos del laboratorio a la atención al paciente

La investigación es cómo pasamos de la esperanza a la cura.

Por eso camino.

Únete a mí o apoya la causa hoy mismo.

I walk because cancer is not just a diagnosis. It’s a life-changing moment for patients and families.

Every day at , I see the strength, resilience, and hope of people fighting cancer. The Dolphins Cancer Challenge supports groundbreaking research at Sylvester Comprehensive Cancer Center, research that directly impacts the treatments we can offer.

This year, I’m walking 5 kilometers. Not for the finish line, but for the patients.

If this cause speaks to you, I invite you to join our team or support the mission.

______

Camino porque el cáncer no es solo un diagnóstico. Es un momento que cambia la vida de los pacientes y sus familias.

Cada día, en , veo la fuerza, la resiliencia y la esperanza de las personas que luchan contra el cáncer. El “Dolphins Cancer Challenge” apoya la investigación pionera del Sylvester Comprehensive Cancer Center, investigación que impacta directamente en los tratamientos que ofrecemos.

Este año, caminaré 5 kilómetros. No por la meta, sino por los pacientes.

Si te identificas con esta causa, te invito a unirte a nuestro equipo o a apoyar la misión.

Once again, I’m proud to join the Dolphins Cancer Challenge 2026 with CB Oncology Partners and the NHMA Florida Chapter!

This year, I’ll be walking 5 kilometers to raise funds in support of groundbreaking cancer research at Sylvester Comprehensive Cancer Center. Together, we can reach this goal, and beyond.

💙 Want to be part of the challenge? Whether you ride, run, or walk, you can join our team and make a difference.

👉 Donate in this post or register today in the link in my bio.

______

Una vez más, me enorgullece unirme al Dolphins Cancer Challenge 2026 con CB Oncology Partners y el Capítulo Florida de la NHMA.

Este año recorreré 5 kilómetros para recaudar fondos en apoyo a la investigación innovadora contra el cáncer en el Sylvester Comprehensive Cancer Center. Juntos podemos alcanzar esta meta y mucho más.

💙 ¿Quieres unirte al reto? Puedes participar corriendo, caminando o pedaleando con nuestro equipo y así marcar la diferencia.

👉 Dona en este post o inscríbete hoy en el enlace en la bio.

Attended a powerful session at “The Low-Down on Low Dose: The Benign Opportunity”
with Dr. M. Heinrich Seegenschmiedt highlighted decades of data showing that low-dose radiation can be a safe, effective, and evidence-based option for selected benign conditions, when applied thoughtfully and collaboratively.

What stood out most:
• Strong response rates supported by long-term studies
• Minimal side effects
• A renewed opportunity to bridge historical medicine with modern, patient-centered care

This session was a reminder that innovation isn’t always about what’s new, sometimes it’s about re-examining proven approaches with today’s tools and standards.



👉 Follow for more insights or share with a colleague.

I’m honored to share that I’ve been recognized as a Fellow of the American College of Radiation Oncology.
Being named a Fellow by a professional society means being recognized by peers as a physician committed to excellence, leadership, and continuous improvement in patient care. ACRO’s mission is to support radiation oncology professionals through career development and practice improvement, always with the goal of enhancing the care we provide to our patients.

This recognition reflects the work we do every day and the trust our patients place in us. I’m grateful to be part of a community that values quality, safety, and evidence-based care.

👉 Learn more about what this recognition means and why it matters for patients (link in bio).

-—

Me honra compartir que he sido reconocido como “Fellow of the American College of Radiation Oncology”.

Ser Fellow de una sociedad profesional significa ser reconocido por colegas como un médico comprometido con la excelencia, el liderazgo y la mejora continua en la atención al paciente. La misión de ACRO es apoyar a los profesionales de radio-oncología mediante el desarrollo profesional y la optimización de la práctica clínica, siempre con el objetivo de brindar una mejor atención a nuestros pacientes.

Este reconocimiento refleja el trabajo que realizamos día a día y la confianza que nuestros pacientes depositan en nosotros. Me siento profundamente agradecido de formar parte de una comunidad que valora la calidad, la seguridad y la medicina basada en evidencia.

👉 Conoce más sobre lo que significa este reconocimiento y por qué es importante para los pacientes (link en la bio).

At , I attended an insightful session sponsored by Varian focused on Low-Dose Radiotherapy (LDRT) for osteoarthritis, a treatment approach with growing evidence and renewed interest.

Key takeaways from the session:
• LDRT is a safe option with minimal side effects, supported by over 100 years of clinical experience
• Data show an efficacy of approximately 70%, now supported by randomized studies
• LDRT does not limit future options, such as surgery or injections
• It offers a meaningful alternative for patients who are not surgical candidates or cannot tolerate medications like NSAIDs
• Functional radiotherapy programs can be clinically and financially beneficial to health systems

These conversations reinforce how radiation oncology continues to expand beyond cancer care, offering innovative, evidence-based solutions that improve quality of life for our patients.

Happening now at —
Theranostics in Radiation Oncology: Building Programs, Empowering Teams, Shaping the Future.
An outstanding session led by Brandon R. Mancini, MD, MBA, Medical Director at BAMF Health, highlighting how theranostics programs can be built thoughtfully, supported by strong teams, and scaled to expand access and impact.
These conversations are critical as we continue shaping the future of precision oncology through collaboration, innovation, and education.

Follow for more updates